References
- Denning DW. Invasive aspergillosis. Clin Infect Dis 1998; 26: 781–803.
- Armenian HK, Lilienfeld AM. Incubation period of disease. Epidemiol Rev 1983; 5: 1–15.
- Nishiura H. Early efforts in modeling the incubation period of infectious diseases with an acute course of illness. Emerg Themes Epidemiol 2007; 4: 2.
- Bowden RA, Ljungman P, Paya CV, (eds). Transplant Infections. 2nd edn. Philadelphia, PA: Lippincott Williams and Wilkins; 2003: 589–607.
- Anderson RM, May RM (eds). Infectious Diseases of Humans. Oxford: Oxford University Press; 1991.
- Sartwell PE. The distribution of incubation periods of infectious disease. Am J Hyg 1950; 51: 310–318.
- Philippe P. Sartwell's incubation period model revisited in the light of dynamic modeling. J Clin Epidemiol 1994; 47: 419–433.
- Lee E. Wenyu Wang J. Some well known parametric survival distributions and their applications. In: Statistical Methods for Survival Data Analysis, 3rd edn. New York, NY: John Wiley & Sons; 2003: 134–161.
- Gerson SL, Talbot GH, Hurwitz S, . Prolonged granulocytopenia: the major risk factor for invasive aspergillosis in patients with acute leukemia. Ann Int Med 1984; 100: 345–351.
- Vanhems P, Voirin N, Philippe P, . and Swiss HIV Cohort Study. The incubation period of acute retroviral syndrome as a multistep process: a parametric survival analysis. J Acquir Immune Defic Syndr 2004; 37: 1529–1533.
- Bénet T, Nicolle MC, Thiebaut A, . Reduction of invasive aspergillosis incidence among immunocompromised patients after control of environmental exposure. Clin Infect Dis 2007; 45: 682–686.
- Nicolle MC, Bénet T, Thiebaut A, . Invasive aspergillosis in patients with hematological malignancies: incidence and description of 127 cases enrolled in a single institution prospective survey from 2004 to 2009. Haematologica 2011; 96: 1685–1691.
- De Pauw B, Walsh TJ, Donnelly JP, . and European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813–1821.
- Lessler J, Reich NG, Brookmeyer R, . Incubation periods of acute respiratory viral infections: a systematic review. Lancet Infect Dis 2009; 9: 291–300.
- Sopena N, Sabrià M; Neunos 2000 Study Group. Multicenter study of hospital-acquired pneumonia in non-ICU patients. Chest 2005; 127: 213–219.
- Kusne S, Krystofiak S. Infection control issues after solid organ transplantation. In: Bowden RA, Ljungman P, Paya CV (eds). Transplant Infections, 2nd edn. Philadelphia, PA: Lippincott Williams and Wilkins; 2003; 589–607.
- Nawada R, Amitani R, Tanaka E, . Murine model of invasive pulmonary aspergillosis following an earlier stage, non-invasive Aspergillus infection. J Clin Microbiol 1996; 34: 1433–1439.
- Ben-Ami R, Lewis RE, Kontoyiannis DP. Enemy of the (immunosuppressed) state: an update on the pathogenesis of Aspergillus fumigatus infection. Br J Haematol 2010; 150: 406–417.